antitrypsin predominant protease inhibitor human plasma despite prime function inhibitor neutrophil elastase archetype family protease inhibitors serpins characteristically mw NUMBER highly ordered tertiary structure role protector vulnerable tissues digestion leukocyte enzymes plasma deficiency predisposes premature emphysema northern europeans uniquely susceptible deficiency frequency mutants z s having substitutions glutamic acids form key salt bridges molecule reactive center antitrypsin labile methionine allows leucocytes switch inhibitory activity contributes accelerated lung degeneration cigarette smokers plasma replacement therapy option treatment approach avoid smoking environmental irritants